» Articles » PMID: 3275583

Control of Endotoxin Activity and Interleukin-1 Production Through Regulation of Lipopolysaccharide-lipoprotein Binding by a Macrophage Factor

Overview
Journal Infect Immun
Date 1988 Jan 1
PMID 3275583
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Lipopolysaccharides (LPSs) extracted from gram-negative bacteria are much less active when bound to serum lipoproteins. We present evidence here that the binding of radiolabeled LPS extracted from Escherichia coli O113 and Salmonella typhimurium to lipoproteins in rabbit serum is increased 8 to 24 h after a single intravenous injection of homologous or heterologous LPS. Supernatants of activated macrophages containing interleukin-1 also stimulate increased binding. The isolated product of this binding does not induce the production of interleukin-1 by macrophages in vivo or in vitro and is unable itself to stimulate increased binding of LPS to lipoprotein. Normal rabbit sera spiked with lipoprotein fractions prepared from tolerant but not normal rabbit sera bind increased amounts of LPS. These data suggest that there may exist a self-regulated mechanism for decreasing the toxicity of LPS and the production of LPS-induced interleukin-1; this mechanism is controlled by a macrophage factor and functions through altering the binding of LPS to certain serum lipoproteins.

Citing Articles

Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.

Netea M, Demacker P, Kullberg B, Boerman O, Verschueren I, Stalenhoef A J Clin Invest. 1996; 97(6):1366-72.

PMID: 8617867 PMC: 507194. DOI: 10.1172/JCI118556.


Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I.

Flegel W, Baumstark M, Weinstock C, Berg A, Northoff H Infect Immun. 1993; 61(12):5140-6.

PMID: 8225591 PMC: 281294. DOI: 10.1128/iai.61.12.5140-5146.1993.


Influence of polyclonal immunoglobulins on the polymorphonuclear leukocyte response to lipopolysaccharide of Salmonella enteritidis as measured with luminol-enhanced chemiluminescence.

Wagner D, Heinrich D Infect Immun. 1994; 62(10):4320-4.

PMID: 7927690 PMC: 303111. DOI: 10.1128/iai.62.10.4320-4324.1994.


Antiendotoxin monoclonal antibodies. What future now?.

Susla G, Dew R Drug Saf. 1994; 11(4):215-22.

PMID: 7848542 DOI: 10.2165/00002018-199411040-00001.


Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins.

Flegel W, Wolpl A, Mannel D, Northoff H Infect Immun. 1989; 57(7):2237-45.

PMID: 2731990 PMC: 313866. DOI: 10.1128/iai.57.7.2237-2245.1989.


References
1.
Gallin J, Kaye D, Oleary W . Serum lipids in infection. N Engl J Med. 1969; 281(20):1081-6. DOI: 10.1056/NEJM196911132812001. View

2.
FREEDMAN H . Passive transfer of protection against lethality of homologous heterologous endotoxins. Proc Soc Exp Biol Med. 1959; 102:504-6. DOI: 10.3181/00379727-102-25296. View

3.
Romeo D, Girard A, Rothfield L . Reconstitution of a functional membrane enzyme system in a monomolecular film. I. Formation of a mixed monolayer of lipopolysaccharide and phospholipid. J Mol Biol. 1970; 53(3):475-90. DOI: 10.1016/0022-2836(70)90078-1. View

4.
SKARNES R . The inactivation of endotoxin after interaction with certain proteins of normal serum. Ann N Y Acad Sci. 1966; 133(2):644-62. DOI: 10.1111/j.1749-6632.1966.tb52395.x. View

5.
Burstein M, Scholnick H, Morfin R . Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970; 11(6):583-95. View